Skip to content

Bio-Medicus™ 96820-112Recalls & reported problems

Medtronic, Inc. · CANNULA 96820-112 BIO-MED ART 12FR · Class 2

All models of Bio-Medicus (59)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169623118), received between Dec 10, 2024 and Dec 10, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).

1 other recall cover devices cleared under the same FDA submission (K143083); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fluid/Blood Leak1
  • Material Separation1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 10, 2024Fluid/Blood Leak; Material Separation; Fluid/Blood Leak; Material Separation

    MEDTRONIC RECEIVED INFORMATION THAT DURING USE OF A BIO-MEDICUS NEXTGEN PEDIATRIC ARTERIAL CANNULA, IT WAS REPORTED THAT DURING THE ARTERIAL CANNULATION, THE OBTURATOR OF THE ARTERIAL CANNULA DID NOT FORM A SUFFICIENT SEAL WITH THE CANNULA CAP. EXCESSIVE BLOOD LEAKED FROM AROUND THE OBTURATOR WHEN IT HAD BEEN PULLED BACK APPROXIMATELY AN INCH. NO CANNULA CHANGEOUT OCCURRED. THE OBTURATOR WAS REMOVED AND BYPASS CONNECTIONS CONTINUED AS NORMAL. ONCE THE ARTERIAL CANNULA WAS APPROPRIATELY CONNECTED TO THE PUMP, THE PATIENT WAS TRANSFUSED TO REPLACE LOST VOLUME.

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 20892099 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K143083. One submission often covers many models, so check the product and lot details in each record.

  • Z-0640-2018 · Sep 21, 2017 · Terminated
    GastriSail" Gastric Positioning Device Product Usage: The GastriSail gastric positioning system is indicated for use in gastric and bariatric surgical procedures for the applicati

Other CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS devices

All CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page